Company: WELNF
Filing Date: 2025-11-12
Form Type: DEFM14A
Source: 0001104659-25-109577
Chunk: 278

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-12
Form: DEFM14A
Chunk 278
---
 listing requirements at or immediately following the Closing;

•

Shareholder Vote. The risk that IWAC’s shareholders may fail to provide the votes necessary to effect the Business Combination;

•

Closing Conditions. The fact that the completion of the Business Combination is conditioned on the satisfaction of certain closing conditions that are not within IWAC’s control;

•

Litigation. The possibility of litigation challenging the Business Combination or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin consummation of the Business Combination; as of the date of this joint proxy statement/information statement/prospectus, no such litigation has been initiated;

•

Listing Risks. The challenges associated with preparing Btab, a private entity, for the applicable disclosure and listing requirements to which Btab will be subject as a publicly traded company on the NYSE (or, to the extent applicable, another exchange);

•

Benefits May Not Be Achieved. The risks that the potential benefits of the Business Combination may not be fully achieved or may not be achieved within the expected timeframe;

•

Liquidation of IWAC. The risks and costs to IWAC if the Business Combination is not completed, including the risk of diverting management focus and resources from other business combination opportunities, which could result in IWAC being unable to effect a business combination within the applicable time frame or to obtain shareholder approval for a further extension thereof;

•

Growth Initiatives May Not be Achieved. The risk that Btab growth initiatives may not be fully achieved or may not be achieved within the expected timeframe;

•

Board and Independent Committees. The risk that the board of directors and independent committees of Pubco do not possess adequate skills set within the context of Btab operating as a public company;

•

IWAC Shareholders Receiving a Minority Position in Btab. The risk that IWAC shareholders will hold a minority position in Btab;

•

Fees and Expenses and Time Risk. The fees and expenses associated with completing the Business Combination and the substantial time and effort of management required to complete the Business Combination;

•

Projections or Forecasts. The risk that any projections/forecasts provided by Btab may not be realized as expected or on the timelines presented;

•

Other Risk Factors. Various other risk factors associated with the business of Btab, as described in the section entitled “ Risk Factors ” appearing elsewhere in this joint proxy statement/information statement/prospectus.

The above discussion of the material factors considered by the IWAC Board is not intended to be exhaustive, but does set forth the principal factors considered by the IWAC Board